Professor Gavin Giovannoni MBBCh, PhD, FCP (S.A., Neurol.), FRCP, FRCPath
Gavin was appointed to the Chair of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, in November 2006. In 2008 he took over as the Neuroscience and Trauma Centre Lead in the Blizard Institute.
Gavin did his undergraduate medical training at the University of the Witwatersrand, South Africa. He graduated cum laude in 1987 winning the prizes for best graduate in medicine and surgery. After completing his neurology specialist training in South Africa he moved to the Institute of Neurology, Queen Square, London in 1993.
After three years as a clinical research fellow, under Professor Ed Thompson, and then two years as the Scarfe Lecturer, working for Professor W. Ian McDonald, he was awarded a PhD in immunology from the University of London in 1998.
DrK (Klaus Schmierer, MB BS, PhD FRCP)
Is a Reader in Clinical Neurology & Consultant Neurologist.
DrK has given evidence as an expert witness in medico-legal cases, and advised in patent dispute cases.
Gavin was appointed to the Chair of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, in November 2006. In 2008 he took over as the Neuroscience and Trauma Centre Lead in the Blizard Institute.
Gavin did his undergraduate medical training at the University of the Witwatersrand, South Africa. He graduated cum laude in 1987 winning the prizes for best graduate in medicine and surgery. After completing his neurology specialist training in South Africa he moved to the Institute of Neurology, Queen Square, London in 1993.
After three years as a clinical research fellow, under Professor Ed Thompson, and then two years as the Scarfe Lecturer, working for Professor W. Ian McDonald, he was awarded a PhD in immunology from the University of London in 1998.
He was appointed as a Clinical Senior Lecturer, Royal Free and University College Medical School, in 1998.
He moved back to Institute of Neurology, Queen Square in 1999 and was made a Reader in Neuroimmunology in 2004. He spent 13 years of his life working at The National Hospital for Neurology and Neurosurgery, Queen Square, London.
He moved back to Institute of Neurology, Queen Square in 1999 and was made a Reader in Neuroimmunology in 2004. He spent 13 years of his life working at The National Hospital for Neurology and Neurosurgery, Queen Square, London.
Gavin's clinical interests are multiple sclerosis and other inflammatory disorders of the central nervous system. He is particularly interested in clinical issues related to optimising MS disease modifying therapies.
His current research is focused on Epstein Barr virus as a possible cause of multiple sclerosis, multiple sclerosis related neurodegeneration, biomarker discovery and immune tolerance strategies.
Follow @gavingiovannoni on twitter.
MouseDoctor. Has an ology.
His current research is focused on Epstein Barr virus as a possible cause of multiple sclerosis, multiple sclerosis related neurodegeneration, biomarker discovery and immune tolerance strategies.
Follow @gavingiovannoni on twitter.
MouseDoctor. Has an ology.
The MouseDoctor spent his academic career based at different places of the University of London . He was awarded a BSc (Hons) in Zoology from Bedford College in 1983 and was awarded a PhD from London University in Immunology/Pathology in 1987 for work at the Institute of Basic medical Science on immunological tolerance induction in delayed hypersensitivity of the skin. He then spent six years as the Angela Limerick lecturer, for multiple sclerosis research at the Hunterian Institute, The Royal College of Surgeons of England working on delayed hypersensitivity in the brain, where he developed an active research interest in multiple sclerosis. He took a 5 year Principal Fellowship to the Institute of Ophthalmology , University College London in 1994 and became the first Senior Fellow of the Multiple Sclerosis Society and moved to the Institute of Neurology , University College London in 1999. He became a senior lecturer in 2003 and got a personal chair in 2004 as Professor of Neuroimmunology. He moved to Queen Mary in the autumn of 2006. He has been investigating the development of experimental treatments for relapsing and progressive MS and in the development of symptom control agents, some of which have ben tested in humans and some of which have become treatments for MS.
Follow @prof_mouse on twitter.
MouseDoctorII was been working with MD since his time at the Institute of Ophthalmology and has a degree in Microbiology from the University of Bath and PhD from the University of London. Before that MD2 had a research interest in immunology and blood brain barrier function.Follow @prof_mouse on twitter.
DrK (Klaus Schmierer, MB BS, PhD FRCP)
Is a Reader in Clinical Neurology & Consultant Neurologist.
Multiple sclerosis has been a focus of DrK's clinical and research activities from the beginning of his training in neurology at the Charité Hospital (Humboldt University), which followed undergraduate studies in Berlin and Jerusalem. In 2001 DrK moved to London to pursue a career in academic neurology, initially as a Research Fellow, and from 2005 as a Wellcome Intermediate Clinical Fellow at the UCL Institute of Neurology, and Consultant Neurologist at The National Hospital for Neurology & Neurosurgery, Queen Square. Here, he investigated the histo-pathological correlates of quantitative MRI using standard and high-field MR systems to improve disease monitoring in people with MS.
Following appointments in 2009 at Queen Mary University of London (QMUL) and The Royal London Hospital (Barts Health NHS Trust) DrK's clinical academic work now includes (i) exploring the pathological substrate of disease deterioration in pwMS using MRI and quantitative histology; (ii) the epidemiology of MS in east London, (iii) the BartsMS Database; (iv) in vivo MRI studies to improve the diagnosis of MS, and (v) investigator-led and commercial clinical trials.
DrK is the Clinical Lead of Neuroscience & Trauma at the Blizard Institute of QMUL and Deputy Director of the Research & Development Board in the Emergency Care & Acute Medicine Clinical Academic Group of Barts Health. He is the Chair of the White Matter Disease Study Group of the International Society for Magnetic Resonance in Medicine (ISMRM). DrK also serves on the Clinical Trials Network and Review Boards of the MS Tissue Bank and MS Register of the Multiple Sclerosis Society of Great Britain & Northern Ireland, and advises the EMA and the MHRA on new drugs for MS.
DrK has given evidence as an expert witness in medico-legal cases, and advised in patent dispute cases.
The research pursued by DrK's group is currently supported by Barts Charity, the Royal College of Radiologists, the MS Societies of Great Britain & Northern Ireland and the USA, ECTRIMS and industry partners (Novartis & Biogen).
DrK is a principal investigator of trials sponsored by Novartis,
Roche, Teva and Medday. He is involved as a co-investigator in trials sponsored by Biogen, Genzyme, BIAL, Cytokinetics and Canbex. He has received speaking honoraria from, and/or served in an advisory role for, Biogen, Novartis, Teva, Merck, Merck Inc, and has been supported by Genzyme to attend AAN 2014, and by Novartis to attend AAN 2016.
Follow @KlausSchmierer on Twitter
Neuro Doc Gnanapavan aka NDG
(Dr Sharmilee Gnanapavan BMedSci (Hons), MB BS, MRCP, MRCP (Neurol), PhD)
Neuro Doc Gnanapavan qualified from St Bartholomews and The Royal London School of Medicine & Dentistry. She specialised in neurology and academically in neuroscience with a PhD from the Institute of Neurology (UCL) entitled "Putative biomarkers of Neuro-restoration". Her current NHS base is Barts Health NHS Trust (St Bartholomew's Hospital, London) and Princess Alexandra Hospitals NHS Trust (Princess Alexandra Hospital, Harlow and St Margaret's Hospital, Epping) as Consultant Neurologist. She is also a lecturer at Queen Mary University of London and is on the advisory board for the UK Brain Bank.
Neuro Doc's research focus is body fluid biomarkers, ranging from basic science through to translation work in clinical practice, including clinical trials. She is on the steering committee of the European Biomarker Consortium (BioMS-eu).
Follow @neurognanapavan on Twitter.
Alison (Alison Thomson BSc, MA RCA)
DrK is a principal investigator of trials sponsored by Novartis,
Roche, Teva and Medday. He is involved as a co-investigator in trials sponsored by Biogen, Genzyme, BIAL, Cytokinetics and Canbex. He has received speaking honoraria from, and/or served in an advisory role for, Biogen, Novartis, Teva, Merck, Merck Inc, and has been supported by Genzyme to attend AAN 2014, and by Novartis to attend AAN 2016.
Follow @KlausSchmierer on Twitter
Neuro Doc Gnanapavan aka NDG
(Dr Sharmilee Gnanapavan BMedSci (Hons), MB BS, MRCP, MRCP (Neurol), PhD)
Neuro Doc Gnanapavan qualified from St Bartholomews and The Royal London School of Medicine & Dentistry. She specialised in neurology and academically in neuroscience with a PhD from the Institute of Neurology (UCL) entitled "Putative biomarkers of Neuro-restoration". Her current NHS base is Barts Health NHS Trust (St Bartholomew's Hospital, London) and Princess Alexandra Hospitals NHS Trust (Princess Alexandra Hospital, Harlow and St Margaret's Hospital, Epping) as Consultant Neurologist. She is also a lecturer at Queen Mary University of London and is on the advisory board for the UK Brain Bank.
Neuro Doc's research focus is body fluid biomarkers, ranging from basic science through to translation work in clinical practice, including clinical trials. She is on the steering committee of the European Biomarker Consortium (BioMS-eu).
Follow @neurognanapavan on Twitter.
Alison (Alison Thomson BSc, MA RCA)
Alison is a designer and researcher who has been part of the Barts MS team since 2011. She gained a first class honours degree in Interactive Media Design at The University of Dundee in 2008 before completing her Masters at The Royal College of Art, London in Design Interactions in 2010. She will complete her doctoral studies in the Department of Design at Goldsmiths, University of London in 2018. Her research uses performative design-led interventions to uncover the various ontologies of Multiple Sclerosis. This practice-based research expands on the potential implications for design research in studying enactments of MS and patient experiences through proposing alternative service interactions.
Follow @somehow_related on Twitter
Follow @somehow_related on Twitter
BartsMSBlog a cyborg collective
This is a lab portal for anyone (shy members) in the group to use